Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,055.00    30.00 (0.50%)
Bid:
6,055.00
Ask:
6,060.00
Spread: 5.00 (0.083%)
Market Cap: £5.17b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

9 Nov 2021 07:00

RNS Number : 7218R
DCC PLC
09 November 2021
 

 

9 November 2021

Board Changes

 

Appointment of New Non-Executive Director

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Mr. Alan Ralph as a non-executive Director and member of the Audit Committee with effect from 8 November 2021.

Mr. Ralph is a very experienced business and finance leader having spent almost 20 years with UDG Healthcare plc (formerly United Drug plc). Mr. Ralph spent ten years leading UDG's largest business unit before supporting its strategic transformation as Chief Financial Officer for five years. Mr. Ralph is a Chartered Accountant.

There are no details to be disclosed under Listing Rule 9.6.13 in respect of Mr. Ralph.

Appointment of Workforce Engagement Director

Mr. Mark Ryan, who has been a non-executive Director since November 2017, has been appointed as the designated Director for engagement with the workforce, succeeding Mr. Cormac McCarthy who passed away in July 2021. Mr. Ryan has also been appointed as a member of the Governance and Sustainability Committee. Both appointments take effect from 8 November 2021.

Mark Breuer, Chairman of DCC plc, said:

"I warmly welcome Alan Ralph to the Board. His financial expertise, business leadership experience and knowledge of the healthcare sector will enhance the Board's knowledge in several key areas."

"I am also very pleased that Mark Ryan will take on the important role of workforce engagement Director. Mark has been a valued member of the Board since 2017 and will bring his knowledge of DCC and extensive business experience to the position."

Contact information 

Investor enquiries:

Darragh Byrne, Company Secretary

Rossa White, Head of Group Investor Relations

Tel: +353 1 2799 400

Email: investorrelations@dcc.ie

 

 

Media enquiries:

Powerscourt (Eavan Gannon/Victoria Palmer Moore)

Tel: +44 20 7250 1446

Email: DCC@powerscourt-group.com

 

 

DCC website:

www.dcc.ie

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABPBLTMTTMBMB
Date   Source Headline
15th Jan 20267:00 amRNSLiquid gas acquisitions in four new markets
31st Dec 202511:29 amRNSTotal Voting Rights
31st Dec 202511:29 amRNSTotal Voting Rights
30th Dec 202511:06 amRNSHolding in Company TR-1
30th Dec 202511:06 amRNSHolding in Company TR-1
29th Dec 20251:22 pmRNSHolding in Company TR-1
29th Dec 20251:22 pmRNSHolding in Company TR-1
29th Dec 202512:42 pmRNSHolding in Company TR-1
29th Dec 202512:42 pmRNSHolding in Company TR-1
29th Dec 202512:39 pmRNSHolding in Company TR-1
29th Dec 202512:39 pmRNSHolding in Company TR-1
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 20254:43 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
23rd Dec 202512:55 pmRNSHolding in Company TR-1
19th Dec 20256:00 pmRNSDCC
19th Dec 20256:00 pmRNSDCC
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 202512:55 pmRNSAcquisition of Shares under Tender Offer and TVR
19th Dec 20257:00 amRNSResults of Tender Offer
19th Dec 20257:00 amRNSResults of Tender Offer
18th Dec 20255:46 pmRNSHolding in Company TR-1
18th Dec 20255:46 pmRNSHolding in Company TR-1
17th Dec 20253:46 pmRNSHolding in Company TR-1
15th Dec 20255:01 pmRNSHolding in Company TR-1
11th Dec 20252:40 pmRNSResult of Extraordinary General Meeting
10th Dec 20254:46 pmRNSHolding in Company TR-1
5th Dec 20252:29 pmRNSHolding in Company TR-1
5th Dec 20252:16 pmRNSHolding in Company TR-1
2nd Dec 20256:13 pmRNSHolding in Company TR-1
28th Nov 20256:11 pmRNSTotal Voting Rights
28th Nov 20254:52 pmRNSHolding in Company TR-1
28th Nov 20251:07 pmRNSHolding in Company TR-1
26th Nov 20254:37 pmRNSHolding in Company TR-1
26th Nov 20259:46 amRNSHolding in Company TR-1
25th Nov 20254:36 pmRNSHolding in Company TR-1
24th Nov 20255:26 pmRNSHolding in Company TR-1
21st Nov 20255:36 pmRNSHolding in Company TR-1
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.